Annual EBITDA
-$16.36 M
-$1.08 M-7.05%
December 1, 2023
Summary
- As of February 12, 2025, TNFA annual EBITDA is -$16.36 million, with the most recent change of -$1.08 million (-7.05%) on December 1, 2023.
- During the last 3 years, TNFA annual EBITDA has fallen by -$8.08 million (-97.64%).
- TNFA annual EBITDA is now -97.64% below its all-time high of -$8.28 million, reached on December 1, 2020.
Performance
TNFA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.83 M
+$35.40 K+1.90%
September 1, 2024
Summary
- As of February 12, 2025, TNFA quarterly EBITDA is -$1.83 million, with the most recent change of +$35.40 thousand (+1.90%) on September 1, 2024.
- Over the past year, TNFA quarterly EBITDA has increased by +$3.08 million (+62.81%).
- TNFA quarterly EBITDA is now at all-time high.
Performance
TNFA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$11.38 M
+$2.02 M+15.06%
September 1, 2024
Summary
- As of February 12, 2025, TNFA TTM EBITDA is -$11.38 million, with the most recent change of +$2.02 million (+15.06%) on September 1, 2024.
- Over the past year, TNFA TTM EBITDA has increased by +$4.98 million (+30.44%).
- TNFA TTM EBITDA is now -221.05% below its all-time high of -$3.54 million, reached on March 1, 2020.
Performance
TNFA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TNFA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.0% | +62.8% | +30.4% |
| 3 y3 years | -97.6% | +50.8% | +23.1% |
| 5 y5 years | -97.6% | +24.8% | -26.4% |
TNFA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -7.0% | +44.1% | at high | +68.4% | at high | +63.3% |
| 5 y | 5-year | -97.6% | +44.1% | at high | +89.9% | -221.1% | +63.3% |
| alltime | all time | -97.6% | +44.1% | at high | +89.9% | -221.1% | +63.3% |
TNF Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.83 M(-1.9%) | -$11.38 M(-15.1%) |
| Jun 2024 | - | -$1.86 M(-33.2%) | -$13.40 M(-22.6%) |
| Mar 2024 | - | -$2.78 M(-43.3%) | -$17.32 M(+5.9%) |
| Dec 2023 | -$16.36 M(+7.0%) | -$4.91 M(+27.7%) | -$16.36 M(+7.2%) |
| Sep 2023 | - | -$3.84 M(-33.5%) | -$15.26 M(+0.9%) |
| Jun 2023 | - | -$5.78 M(+216.4%) | -$15.13 M(+16.5%) |
| Mar 2023 | - | -$1.83 M(-52.0%) | -$12.99 M(-15.0%) |
| Dec 2022 | -$15.28 M | -$3.81 M(+2.6%) | -$15.28 M(+3.2%) |
| Sep 2022 | - | -$3.71 M(+1.8%) | -$14.81 M(-10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$3.64 M(-11.6%) | -$16.56 M(-46.5%) |
| Mar 2022 | - | -$4.12 M(+23.7%) | -$30.97 M(+5.8%) |
| Dec 2021 | -$29.28 M(+253.7%) | -$3.33 M(-39.0%) | -$29.28 M(-4.3%) |
| Sep 2021 | - | -$5.47 M(-69.7%) | -$30.58 M(+13.0%) |
| Jun 2021 | - | -$18.05 M(+643.1%) | -$27.06 M(+200.5%) |
| Mar 2021 | - | -$2.43 M(-47.6%) | -$9.00 M(-11.0%) |
| Dec 2020 | -$8.28 M | -$4.63 M(+138.9%) | -$10.12 M(+84.5%) |
| Sep 2020 | - | -$1.94 M(-45.3%) | -$5.48 M(+54.7%) |
| Mar 2020 | - | -$3.54 M | -$3.54 M |
FAQ
- What is TNF Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals annual EBITDA year-on-year change?
- What is TNF Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals quarterly EBITDA year-on-year change?
- What is TNF Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals TTM EBITDA year-on-year change?
What is TNF Pharmaceuticals annual EBITDA?
The current annual EBITDA of TNFA is -$16.36 M
What is the all time high annual EBITDA for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high annual EBITDA is -$8.28 M
What is TNF Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, TNFA annual EBITDA has changed by -$1.08 M (-7.05%)
What is TNF Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of TNFA is -$1.83 M
What is the all time high quarterly EBITDA for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high quarterly EBITDA is -$1.83 M
What is TNF Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, TNFA quarterly EBITDA has changed by +$3.08 M (+62.81%)
What is TNF Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of TNFA is -$11.38 M
What is the all time high TTM EBITDA for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high TTM EBITDA is -$3.54 M
What is TNF Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, TNFA TTM EBITDA has changed by +$4.98 M (+30.44%)